Correlation Between Lyell Immunopharma and Amicus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyell Immunopharma and Amicus Therapeutics, you can compare the effects of market volatilities on Lyell Immunopharma and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Amicus Therapeutics.

Diversification Opportunities for Lyell Immunopharma and Amicus Therapeutics

-0.09

Correlation Coefficient

Lyell Immunopharma  Amicus Therapeutics

Good diversification

The 3 months correlation between Lyell and Amicus is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Amicus Therapeutics go up and down completely randomly.

Pair Corralation between Lyell Immunopharma and Amicus Therapeutics

Given the investment horizon of 90 days Lyell Immunopharma is expected to generate 3.19 times more return on investment than Amicus Therapeutics. However, Lyell Immunopharma is 3.19 times more volatile than Amicus Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  62.00  in Lyell Immunopharma on December 28, 2024 and sell it today you would lose (3.00) from holding Lyell Immunopharma or give up 4.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyell Immunopharma  vs.  Amicus Therapeutics

Lyell Immunopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lyell Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Lyell Immunopharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Lyell Immunopharma and Amicus Therapeutics

The main advantage of trading using opposite Lyell Immunopharma and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.

The idea behind Lyell Immunopharma and Amicus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.